Millendo Reports Third Quarter 2019 Operating and Financial Results; Livoletide pivotal study in PWS completed recruitment and is on track to report topline results in 1H20; Nevanimibe Phase 2b study in CAH continues recruitment, topline results expected
Business Wire: November 13, 2019
Go back to Press Page
